Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)

Treatment of mucopolysaccharidosis II with recombinant human iduronate-2-sulfatase (IDS)

US Patent 11986515 · Granted May 21, 2024

Estimated economic value: $10,844,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

System for sutureless closure of scleral perforations and other ocular tissue di2022
System for sutureless closure of scleral perforations and other ocular tissue di2019